Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party.

Penack, Olaf; Peczynski, Christophe; van der Werf, Steffie; Finke, Jürgen; Ganser, Arnold; Schoemans, Helene; Pavlu, Jiri; Niittyvuopio, Riitta; Schroyens, Wilfried; Kaynar, Leylagül; Blau, Igor W; van der Velden, Walter; Sierra, Jorge; Cortelezzi, Agostino; Wulf, Gerald; Turlure, Pascal; Rovira, Montserat; Ozkurt, Zubeydenur; Pascual-Cascon, Maria J; Moreira, Maria C; Clausen, Johannes; Greinix, Hildegard; Duarte, Rafael F; Basak, Grzegorz W

Penack, Olaf; Peczynski, Christophe; van der Werf, Steffie; Finke, Jürgen; Ganser, Arnold; Schoemans, Helene; Pavlu, Jiri; Niittyvuopio, Riitta; Schroyens, Wilfried; Kaynar, Leylagül; Blau, Igor W; van der Velden, Walter; Sierra, Jorge; Cortelezzi, Agostino; Wulf, Gerald; Turlure, Pascal; Rovira, Montserat; Ozkurt, Zubeydenur; Pascual-Cascon, Maria J; Moreira, Maria C; Clausen, Johannes; Greinix, Hildegard; Duarte, Rafael F; Basak, Grzegorz W.

Afiliação

Penack O; Charité Universitätsmedizin Berlin, Berlin, Germany.
Peczynski C; EBMT Statistical Unit, Paris, France.
van der Werf S; EBMT Data Office, Leiden, the Netherlands.
Finke J; University of Freiburg, Freiburg, Germany.
Ganser A; Hannover Medical School, Hannover, Germany.
Schoemans H; Department of Hematology, University Hospital Leuven and KU Leuven, Leuven, Belgium.
Pavlu J; Imperial College, London, UK.
Niittyvuopio R; HUCH Comprehensive Cancer Center, Helsinki, Finland.
Schroyens W; Antwerp University Hospital, Antwerp, Belgium.
Kaynar L; Erciyes University Medical Faculty, Kayseri, Turkey.
Blau IW; Charité Universitätsmedizin Berlin, Berlin, Germany.
van der Velden W; Radboud University - Nijmegen Medical Centre, Nijmegen, the Netherlands.
Sierra J; Hospital Santa Creu I Sant Pau, Barcelona, Spain.
Cortelezzi A; Fondazione IRCCS - Ca'Granda, Milan, Italy.
Wulf G; Universitätsklinikum Göttingen, Göttingen, Germany.
Turlure P; CHRU Limoges, Limoges, France.
Rovira M; Hospital Clinic, Barcelona, Spain.
Ozkurt Z; Gazi University Faculty of Medicine, Ankara, Turkey.
Pascual-Cascon MJ; Hospital Regional de Málaga, Malaga, Spain.
Moreira MC; Instituto National do Cancer, Rio de Janeiro, Brazil.
Clausen J; Elisabethinen-Hospital, Linz, Austria.
Greinix H; LKH - University Hospital Graz, Graz, Austria.
Duarte RF; Hospital Universitario Puerta de Hierro, Madrid, Spain.
Basak GW; Medical University of Warsaw, Warsaw, Poland.

Haematologica ; 105(7): 1977-1983, 2020 07.

Article em En | MEDLINE | ID: mdl-31601686

Assuntos

Doença Enxerto-Hospedeiro; Transplante de Células-Tronco Hematopoéticas; Doença Enxerto-Hospedeiro/etiologia; Transplante de Células-Tronco Hematopoéticas/efeitos adversos; Humanos; Estudos Prospectivos; Estudos Retrospectivos; Condicionamento Pré-Transplante/efeitos adversos; Transplante Homólogo; Ácido Úrico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google